High oleic acid canola oil

OTHER3 trials

Sponsors

Penn State University, University of Manitoba

Conditions

Cardiovascular DiseaseMetabolic Syndrome

Unknown Phase

Canola Oil Multicentre Intervention Trial (COMIT)

CompletedNCT01233778

Penn State UniversityCardiovascular Disease

Start: 2010-10-31End: 2012-04-30Updated: 2023-08-21

Canola Oil Multicentre Intervention Trial

CompletedNCT01351012

University of ManitobaMetabolic Syndrome

Start: 2010-09-30End: 2012-04-30Updated: 2014-02-19

Canola Oil Multi-center Intervention Trial II

CompletedNCT03054779

Penn State UniversityCardiovascular Disease, Metabolic Syndrome

Start: 2014-09-30End: 2016-11-30Updated: 2023-08-21

Related Papers

Diets Low in Saturated Fat with Different Unsaturated Fatty Acid Profiles Similarly Increase Serum-Mediated Cholesterol Efflux from THP-1 Macrophages in a Population with or at Risk for Metabolic Syndrome: The Canola Oil Multicenter Intervention Trial.

2018-05-0113 citations

DHA-enriched high-oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trial.

2014-05-1471 citations

Plasma fatty acid changes following consumption of dietary oils containing n-3, n-6, and n-9 fatty acids at different proportions: preliminary findings of the Canola Oil Multicenter Intervention Trial (COMIT).

2014-04-2331 citations